Selective CETP inhibition and PPARalpha agonism increase HDL cholesterol and reduce LDL cholesterol in human ApoB100/human CETP transgenic mice.
Hansen
Michael K
MK
Discovery Research, GlaxoSmithKline, King of Prussia, PA, USA. mkhansen99@yahoo.com
McVey
Matthew J
MJ
White
Ray F
RF
Legos
Jeffrey J
JJ
Brusq
Jean-Marie
JM
Grillot
Didier A
DA
Issandou
Marc
M
Barone
Frank C
FC